RVTYRevvity

$154.08+76% 1Y

Is it growing?

Watch

Growth is fading: earnings down −11% year on year and operating margin narrowing (−1.2 points).

2 to watch, 1 neutral
Revenue trend+4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −7% a year.

Earnings trend−11% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−1.2 points operating

Trailing-twelve-month operating margin, 12.3% now against 13.5% a year earlier.

All from SEC EDGAR, as of Jul 5, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 75% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RVTY growing?

Revvity has grown revenue 0.87% a year over three years and −7.3% a year over five, with earnings per share compounding at −31%.

+0.87%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
−7.3%

Revenue growth, 5-year rate · +0.87% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
−31%

Earnings per share, 3-year rate · revenue +0.87% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2008 to FY2025, as filed

Details›
Revenue FY2021
$3.83B
Revenue FY2022
$3.31B
Revenue FY2023
$2.75B
Revenue FY2024
$2.76B
Revenue FY2025
$2.86B

Annual income statements as filed with the SEC.